Julie Xing
Direttore/Membro del Consiglio presso APTARGROUP, INC.
Patrimonio netto: 398 172 $ in data 31/05/2024
Profilo
Julie Xing is currently the Executive Chairman at Mundipharma (China) Pharmaceutical Co., Ltd.
and an Independent Director at AptarGroup, Inc. She previously worked at Eli Lilly & Co. as the Senior Director-Global New Product Planning from 2010 to 2019.
Julie also held positions at Panomics LLC as the VP, GM-Asia Pacific & Japan Operations, and at Envista Holdings Corp.
as the Global Senior VP & President-Greater China.
She holds a doctorate degree from The Hong Kong University of Science & Technology.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
APTARGROUP, INC.
0.00% | 01/05/2024 | 2 696 ( 0.00% ) | 398 172 $ | 31/05/2024 |
Posizioni attive di Julie Xing
| Società | Posizione | Inizio |
|---|---|---|
| APTARGROUP, INC. | Direttore/Membro del Consiglio | 01/03/2023 |
Mundipharma (China) Pharmaceutical Co., Ltd.
 Mundipharma (China) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Mundipharma International Ltd., Mundipharma (China) Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Beijing, China. | Presidente | 01/03/2023 |
Precedenti posizioni note di Julie Xing
| Società | Posizione | Fine |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2019 |
Panomics LLC
 Panomics LLC Miscellaneous Commercial ServicesCommercial Services Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
| ENVISTA HOLDINGS CORPORATION | Corporate Officer/Principal | - |
Formazione di Julie Xing
| The Hong Kong University of Science & Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| APTARGROUP, INC. | Process Industries |
| ELI LILLY AND COMPANY | Health Technology |
| ENVISTA HOLDINGS CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
Panomics LLC
Panomics LLC Miscellaneous Commercial ServicesCommercial Services Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA. | Commercial Services |
Mundipharma (China) Pharmaceutical Co., Ltd.
Mundipharma (China) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Mundipharma International Ltd., Mundipharma (China) Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Julie Xing
